Prophylactic Indomethacin Revisited - 14/12/17
Doi : 10.1016/j.jpeds.2017.03.036
*Reprint requests: Jeff Reese, MD, Vanderbilt University Medical Center, 1125 MRB IV Bldg, 2215 B Garland Ave, Nashville, TN 37232-0656.Vanderbilt University Medical Center1125 MRB IV Bldg2215 B Garland AveNashvilleTN37232-0656
Elaine L. Shelton, PhD
Department of Pediatrics Department of Pharmacology Vanderbilt University School of Medicine Monroe Carell Jr. Children's Hospital at Vanderbilt Nashville, Tennessee
James C. Slaughter, PhD
Department of Biostatistics Vanderbilt University School of Medicine Nashville, Tennessee
Patrick J. McNamara, MD
Department of Neonatology Department of Physiology and Experimental Medicine Hospital for Sick Children Toronto, Canada
Keywords : ductus arteriosus, prophylaxis, indomethacin, bronchopulmonary dysplasia
Abbreviations : BPD, IVH, NRN, PDA, RCT, TIPP
Le texte complet de cet article est disponible en PDF.
| The authors declare no conflicts of interest. |
© 2017
Elsevier Inc. Tous droits réservés.
Vol 186
P. 11 - juillet 2017 Retour au numéro
Article précédent
- Oxygen Targeting in Infants Born Extremely Preterm Who Are Small for Gestational Age: A Need for Heightened Vigilance
- Barbara Schmidt, Robin K. Whyte, Robin S. Roberts
- Fast, Slow, High, and Low: Infant and Childhood Growth as Predictors of Cardiometabolic Outcomes
- Jessica G. Woo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?